An active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \nAn active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \nEvents and networks managed by the Business Partnerships Office
\n \n\n \n \nThis page contains information about funding opportunities with Industry. If you are thinking of applying, please read all terms and conditions and feel free to get in touch with the named Oxford contact to talk more about the opportunity.
\n \n\n \n \nThe Business Partnerships Office work with businesses looking to collaborate with Oxford\u2019s world-leading medical sciences researchers.
\n \n\n \n \nWe support the establishment and long-term sustainability of strategic research alliances between industry and academia.
\n \n\n \n \nTable showing the adjusted BMAT scores for the 2022 cohort.
\n \n\n \n \nText version of nA*/9/8 and pA* at GCSE (2020)
\n \n\n \n \nRunning GPU accelerated Relion on the BMRC scheduled nodes
\n \n\n \n \n